Advances in molecular classification and precision oncology in hepatocellular carcinoma - Centre de recherche des Cordeliers Accéder directement au contenu
Article Dans Une Revue Journal of Hepatology Année : 2020

Advances in molecular classification and precision oncology in hepatocellular carcinoma

Résumé

Hepatocellular carcinoma (HCC) arises from hepatocytes through the sequential accumulation of multiple genomic and epigenomic alterations resulting from Darwinian selection. Genes from various signalling pathways such as telomere maintenance, Wnt/β-catenin, P53/cell cycle regulation, oxidative stress, epigenetic modifiers, AKT/mTOR and MAP kinase are frequently mutated in HCC. Several subclasses of HCC have been identified based on transcriptomic dysregulation and genetic alterations that are closely related to risk factors, pathological features and prognosis. Undoubtedly, integration of data obtained from both preclinical models and human studies can help to accelerate the identification of robust predictive biomarkers of response to targeted biotherapy and immunotherapy. The aim of this review is to describe the main advances in HCC in terms of molecular biology and to discuss how this knowledge could be used in clinical practice in the future.
Fichier principal
Vignette du fichier
S0168827819304842.pdf (2.06 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03489688 , version 1 (21-07-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Sandra Rebouissou, Jean-Charles Nault. Advances in molecular classification and precision oncology in hepatocellular carcinoma. Journal of Hepatology, 2020, 72 (2), pp.215 - 229. ⟨10.1016/j.jhep.2019.08.017⟩. ⟨hal-03489688⟩
32 Consultations
101 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More